Subclinical thyroid disorders;Subkliniczne schorzenia tarczycy

Polski Merkuriusz Lekarski

Volumn 21, Issue 126, 2006, Pages 573-578

  Krysiak, Robert ^a   Okopień, Bogusław ^a   Herman, Zbigniew Stanisław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Aetiology; Diagnosis; Subclinical hyperthyroidism; Subclinical hypothyroidism; Symptoms and complications; Treatment

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DYSLIPIDEMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK FACTOR; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MASS SCREENING; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; THYROTROPIN; THYROXINE;

EID: 33846364701     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Al-Abadi A.C.: Subclinical thyrotoxicosis. Postgrad. Med. J., 2001, 77, 29-32.
2. Biondi B., Palmieri E.A., Lombardi G. i wsp.: Effects of subclinical thyroid dysfunction on the heart. Ann. Intern. Med., 2002, 137, 904-914.
3. Biondi B., Palmieri E.A., Klain M. i wsp.: Subclinical hyperthyroidism: clinical features and treatment options. Eur. J. Endocrinol., 2005, 152, 1-9.
4. Boelaert K., Franklyn J.A.: Thyroid hormone in health and disease. J. Endocrinol., 2005, 187, 1-15.
5. Burmeister L.A., Flores A.: Subclinical thyrotoxicosis and the heart. Thyroid, 2002, 12, 495-499.
6. Canaris G.J., Manowitz N.R., Mayor G. i wsp.: The Colorado thyroid disease prevalence study. Arch. Intern. Med., 2000, 160, 526-534.
7. Clarke N., Kabadi U.M.: Optimizing treatment of hypothyroidism. Treat. Endocrinol., 2004, 3, 217-221.
8. Cooper D.S.: Clinical practice. Subclinical hypothyroidism. N. Engl. J. Med., 2001, 345, 260-265.
9. Danese M.D., Ladenson P.W., Meinert C.L. i wsp.: Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J. Clin. Endocrinol. Metab., 2000, 85, 2993-3001.
10. Danzi S., Klein I.: Thyroid hormone and the cardiovascular system. Minerva Endocrinol., 2004, 29, 139-150.
11. Duntas L.H.: Subclinical thyroid disorders: the menace of the Trojan horse. J. Endocrinol. Invest., 2003, 26, 472-480.
12. Fatourechi V.: Subclinical thyroid disease. Mayo Clin. Proc., 2001, 76, 413-446.
13. Fatourechi V.: Subclinical hypothyroidism: how should it be managed? Treat. Endocrinol., 2002, 1, 211-216.
14. Fazio S., Palmieri E.A., Lombardi G. i wsp.: Effects of thyroid hormone on the cardiovascular system. Recent. Prog. Horm. Res., 2004, 59, 31-50.
15. Gharib H., Tuttle R.M., Baskin H.J. i wsp.: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J. Clin. Endocrinol. Metab., 2005, 90, 581-585.
16. Glueck C.J., Streicher P.: Cardiovascular and medical ramifications of treatment of subclinical hypothyroidism. Curr. Atheroscler. Rep., 2003, 5, 73-77.
17. Hak A.E., Pols H.A., Visser T.J. i wsp.: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med., 2000, 132, 270-278.
18. Hennessey J.V.: Precise thyroxine dosing: clinical requirements. Endocrinologist, 2003, 13, 479-87.
19. Hoogendoorn E.H., den Heijer M., van Dijk A.P. i wsp.: Subclinical hyperthyroidism: to treat or not to treat? Postgrad. Med. J., 2004, 80, 394-398.
20. Ibay A.D., Bascelli L.M., Nashelsky J.: Management of subclinical hypothyroidism. Am. Fam. Physician, 2005, 71, 1163-1164.
21. Kek P.C., Ho S.C., Khoo D.H.: Subclinical thyroid disease. Singapore Med. J., 2003, 44, 595-600.
22. LeBeau S.O., Mandel S.J.: Thyroid disorders during pregnancy. Endocrinol. Metab. Clin. North Am., 2006, 35, 117-136.
23. LeGrys V.A., Hartmann K., Walsh J.F.: The clinical consequences and diagnosis of hypothyroidism. Clin. Lab. Sci., 2004, 17, 203-208.
24. Mazzaferri E.L.: Finding and treating subclinical hypothyroidism. Hosp. Pract., 2001, 36, 9-10.
25. McDermott M.T., Ridgway E.C.: Subclinical hypothyroidism is mild thyroid failure and should be treated. J. Clin. Endocrinol. Metab., 2001, 86, 4585-4590.
26. Owen P.J., Lazarus J.H.: Subclinical hypothyroidism: the case for treatment. Trends Endocrinol. Metab., 2003, 14, 257-261.
27. Palmieri E.A., Fazio S., Lombardi G. i wsp.: Subclinical hypothyroidism and cardiovascular risk: a reason to treat? Treat. Endocrinol., 2004, 3, 233-244.
28. Poppe K., Velkeniers B.: Female infertility and the thyroid. Best Pract. Res. Clin. Endocrinol. Metab., 2004, 18, 153-165.
29. Surks M.I., Ortiz E., Daniels G.H. i wsp.: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA, 2004, 291, 228-238.
30. Toft A.D.: Clinical practice. Subclinical hyperthyroidism. N. Engl. J. Med., 2001, 345, 512-516.
31. Vanderpump M.: Subclinical hypothyroidism: the case against treatment. Trends Endocrinol. Metab., 2003, 14, 262-266.
32. Vanderpump M.P., Tunbridge W.M.: Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid, 2002, 12, 839-847.
33. Vanderpump M.P., Tunbridge W.M., French J.M. i wsp.: The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol., 1995, 43, 55-68.
34. Wartofsky L., Dickey R.A.: The evidence for a narrower thyrotropin reference range is compelling. J. Clin. Endocrinol. Metab., 2005, 90, 5483-5488.
35. Wilson G.R., Curry R.W. Jr.: Subclinical thyroid disease. Am. Fam. Physician, 2005, 72, 1517-1524.